Blue Sky Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Blue Sky Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	BUY	$64.88 - $73.64 $479,592 - $544,346	7,392 New	7,392 $537,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $204,285 - $228,853	-3,267 Closed	0 $0
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $7,356 - $8,968	-101 Reduced 3.0%	3,267 $246,000
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $3,415 - $4,008	-48 Reduced 1.41%	3,368 $241,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $246,327 - $291,965	3,416	3,416 $277,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Blue Sky Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Blue Sky Wealth Advisors, LLC with notifications on news.